A Single-centre, Open-label, Single-dose Interventional Study Investigating the Pharmacokinetic Properties of Lu AA21004 in Healthy Young Chinese Men and Women

Trial Profile

A Single-centre, Open-label, Single-dose Interventional Study Investigating the Pharmacokinetic Properties of Lu AA21004 in Healthy Young Chinese Men and Women

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jan 2013

At a glance

  • Drugs Vortioxetine (Primary)
  • Indications Anxiety disorders; Depressive disorders; Generalised anxiety disorder; Major depressive disorder
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Oct 2012 Planned initiation date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top